Marco Sifringer Selected Research

CFM 2

1/2018	AMPA Receptor Antagonist CFM-2 Decreases Survivin Expression in Cancer Cells.
12/2007	AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Sifringer Research Topics

Disease

18	Hyperoxia 01/2017 - 08/2003
9	Brain Injuries (Brain Injury) 01/2017 - 01/2005
8	Neoplasms (Cancer) 01/2018 - 10/2005
7	Wounds and Injuries (Trauma) 01/2018 - 11/2002
6	Inflammation (Inflammations) 06/2022 - 12/2008
5	Premature Birth (Birth, Premature) 07/2010 - 06/2007
4	Cognitive Dysfunction 06/2022 - 11/2002
4	Seizures (Absence Seizure) 10/2017 - 11/2002
4	Neuroblastoma 12/2009 - 06/2005
3	Neuroinflammatory Diseases 01/2018 - 01/2013
3	Rhabdomyosarcoma 12/2009 - 10/2005
3	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2007 - 11/2002
2	Cerebral Palsy (Spastic Diplegia) 10/2017 - 06/2007
2	Necrosis 04/2013 - 06/2005
2	Carcinoma (Carcinomatosis) 12/2009 - 10/2009
2	Medulloblastoma 12/2009 - 10/2009
2	Multiple Myeloma 12/2009 - 10/2009
2	Glioma (Gliomas) 12/2009 - 10/2009
2	Adenocarcinoma of Lung 12/2007 - 10/2005
2	Craniocerebral Trauma (Head Injury) 07/2007 - 10/2004
2	Congenital Abnormalities (Deformity) 05/2003 - 11/2002
2	Microcephaly 05/2003 - 11/2002
1	Apnea 10/2017
1	Demyelinating Diseases (Demyelinating Disease) 02/2016
1	Multiple Sclerosis 02/2016
1	Left Ventricular Dysfunction 01/2014
1	Autosomal Recessive Primary Microcephaly 09/2013
1	Bronchopulmonary Dysplasia 04/2013
1	Body Weight (Weight, Body) 04/2013
1	Pneumonia (Pneumonitis) 04/2013
1	Lung Injury 04/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Pain (Aches) 01/2013

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 06/2022 - 11/2002
15	Oxygen (Dioxygen)IBA 01/2017 - 06/2007
7	CytokinesIBA 02/2016 - 03/2007
6	Messenger RNA (mRNA)IBA 01/2018 - 08/2003
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2010 - 10/2005
4	Dexmedetomidine FDA Link 06/2022 - 01/2015
4	Glutamate Receptors (Glutamate Receptor)IBA 01/2018 - 12/2007
4	Erythropoietin FDA Link 01/2016 - 11/2008
4	Interleukin-18 (Interleukin 18)IBA 01/2015 - 01/2005
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2011 - 10/2005
3	LipopolysaccharidesIBA 06/2022 - 01/2012
3	Caffeine (No Doz)FDA LinkGeneric 10/2017 - 04/2013
3	Neuroprotective AgentsIBA 01/2017 - 08/2005
3	Excitatory Amino Acid AntagonistsIBA 02/2011 - 10/2005
3	ProteomeIBA 12/2008 - 07/2007
3	Caspase 3 (Caspase-3)IBA 12/2008 - 06/2005
3	Cyclin D1IBA 12/2007 - 10/2005
2	MicroRNAs (MicroRNA)IBA 06/2022 - 08/2017
2	CFM 2IBA 01/2018 - 12/2007
2	Ionotropic Glutamate ReceptorsIBA 01/2018 - 02/2011
2	PhysostigmineIBA 01/2018 - 01/2013
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2018 - 01/2013
2	Pharmaceutical PreparationsIBA 10/2017 - 09/2008
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 01/2017
2	Cholinergic Agents (Cholinergics)IBA 01/2013 - 07/2010
2	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2013 - 07/2010
2	Malondialdehyde (Propanedial)IBA 01/2013 - 07/2010
2	AcetylcholinesteraseIBA 01/2013 - 07/2010
2	Glutathione (Reduced Glutathione)IBA 01/2013 - 07/2010
2	Glutamic Acid (Glutamate)FDA Link 02/2011 - 10/2009
2	Matrix Metalloproteinases (MMPs)IBA 01/2009 - 03/2007
2	GelatinIBA 01/2009 - 03/2007
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 12/2007 - 10/2005
2	ElementsIBA 12/2007 - 10/2005
2	Carrier Proteins (Binding Protein)IBA 12/2007 - 10/2005
2	Mitogen-Activated Protein Kinase 3IBA 06/2007 - 10/2005
2	InterleukinsIBA 03/2007 - 01/2005
2	CaspasesIBA 10/2004 - 01/2003
2	Anticonvulsants (Antiepileptic Drugs)IBA 05/2003 - 11/2002
1	SurvivinIBA 01/2018
1	AMPA Receptors (AMPA Receptor)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 10/2017
1	methylxanthineIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	NestinIBA 01/2017
1	polysialyl neural cell adhesion moleculeIBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 02/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 02/2016
1	Sphingosine-1-Phosphate ReceptorsIBA 02/2016
1	Tetradecanoylphorbol AcetateIBA 01/2015
1	CyclinsIBA 09/2013
1	Interleukin-6 (Interleukin 6)IBA 04/2013
1	Peroxidase (Myeloperoxidase)IBA 04/2013
1	ChemokinesIBA 04/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2013
1	CC ChemokinesIBA 04/2013
1	CXC ChemokinesIBA 04/2013
1	Chemokine CXCL2IBA 04/2013
1	Protein Kinase C-epsilonIBA 01/2013
1	Analgesics (Analgesic Drugs)IBA 01/2013
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2013
1	Morphine (MS Contin)FDA LinkGeneric 01/2013
1	Cholinergic AgonistsIBA 01/2013

Therapy/Procedure

6	Therapeutics 01/2013 - 11/2002
3	Intraperitoneal Injections 03/2007 - 01/2005
2	Injections 01/2013 - 11/2008
1	Catheters 01/2014